Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Helena H. L. Borba

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

BioDrugs

English

Related publications

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

Journal of Bone and Joint Surgery - Series A

English

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

English

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

English

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

English

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2019

English

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

Clinical Pharmacology and Therapeutics

Pharmacology

2013

English

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Proceedings for Annual Meeting of The Japanese Pharmacological Society

2020

English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

English

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Helena H. L. Borba

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

Related publications

Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)

Pmh6 - Lurasidone Induced Suicidal Ideation and Hallucination: Disproportionality Analysis in Fda Adverse Event Reporting System Database

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System